by PRISMS | Apr 28, 2024 | Clinics, Education, From PRISMS, Home Page, Research
PRISMS is pleased to announce another online publication in its series of family-friendly treatment recommendations. This series is designed to provide essential information to parents, caretakers, and other professionals who may be providing services to an individual...
by PRISMS | Nov 23, 2022 | 30th Anniversary, Awareness, Home Page, Research, SMS Blog
By: Maggie Miller On December 1, 2020, the Food and Drug Administration (FDA) approved the use of HETLIOZ® (tasimelteon) capsule and liquid formulations for the treatment of adults and children, respectively, with nighttime sleep disturbances associated with...
by PRISMS | Jun 6, 2022 | Clinics, Education, From PRISMS, Home Page, Research
By Robert Miller, Advisor on Clinic Relations PRISMS is pleased to announce the online publication of its first in a series of family-friendly treatment recommendations. This series is designed to provide essential information to parents, caretakers, and other...
by PRISMS | Dec 6, 2021 | From PRISMS, Home Page, Research, SMS Blog
By Michelle Larscheid, Program Coordinator PRISMS is excited to be funding Austin Burns, a 4th-year clinical psychology doctoral student at Saint Louis University, to work on developing an intervention for adolescent siblings of individuals with SMS. Dr. Rebecca...
by PRISMS | May 19, 2021 | Home Page, Research
Brenda Finucane, MS, CGCGeisinger Autism & Developmental Medicine Institute, Lewisburg, PA Thanks to strong participation by families in the PRISMS community, my colleagues and I completed a research survey on Birt-Hogg-Dubé syndrome (BHD) symptoms in people with...
by PRISMS | Oct 15, 2020 | From PRISMS, Research, SMS Blog
PRISMS Professional Advisory Board is comprised of some of the world’s foremost experts on Smith-Magenis Syndrome in a wide range of disciplines including speech and language, neurology, psychology, behavior, genetics and more. We are very excited to expand our...
